Composition, form of production and packaging
? Oil for topical application in the form of a readily mobile transparent liquid, colorless or slightly yellowish, with a characteristic aromatic odor.
1 f.
eucalyptus oil 25 ml
25 ml - bottles (1) - packs of cardboard.
64 ml - bottles (1) - cardboard boxes.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2014.
PHARMACHOLOGIC EFFECT
Has antiseptic and anti-inflammatory effect.
INDICATIONS
- inflammatory diseases of the upper respiratory tract (in the form of inhalation);
- inflammatory diseases of the mouth (rinsing).
DOSING MODE
Inhalation: 10-15 cap. oil for 1 glass of hot water. Inhalation is carried out 1-2 times a day.
Locally (for rinses): 10-15 cap. oil for 1 glass of warm water. Rinses of the mouth are carried out 3-4 times a day.
SIDE EFFECT
Allergic reactions are possible.
CONTRAINDICATIONS
- Hypersensitivity to essential oils, including eucalyptus oil.
At inhalation:
- bronchial asthma;
- bronchospasm;
- Whooping cough;
- Children under 2 years.
PREGNANCY AND LACTATION
During pregnancy and during breastfeeding, the use of the drug is not recommended due to the lack of data on the safety of the drug in this category of patients.
APPLICATION FOR CHILDREN
The drug is contraindicated in children under 2 years of age.
SPECIAL INSTRUCTIONS
Impact on the ability to drive vehicles and manage mechanisms.
The adverse effect of the drug on the ability to drive and engage in other activities that require concentration and speed of psychomotor reactions have not been reported.
OVERDOSE
To date, cases of overdose with the use of the drug are not registered.
DRUG INTERACTION
Possible joint use of the drug against the background of other drugs used in the therapy of inflammatory diseases of the upper respiratory tract.
TERMS AND CONDITIONS OF STORAGE
In the dark place at a temperature of 2 to 15 В° C. Keep out of the reach of children. Shelf life - 5 years.
